Mirtazapina Krka (Mirtazapine)

Mirtazapine works by blocking presynaptic α2‑adrenergic receptors, which boosts the release of norepinephrine and serotonin. It also antagonises postsynaptic 5‑HT2 and 5‑HT3 receptors and strongly blocks H1 histamine receptors, resulting in enhanced monoaminergic transmission and the characteristic sedative and appetite‑stimulating effects.

The appropriate dose of Mirtazapina Krka is determined individually by a qualified prescriber based on the patient’s clinical condition, response, and tolerability. Dosage adjustments are made according to professional guidelines and the treating physician’s judgment.

Safety data for mirtazapine in pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Healthcare providers typically evaluate each case carefully and may consider alternative therapies when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature‑controlled requirements) and the necessary import documentation.

Mirtazapine belongs to the NaSSA class, which differs from selective serotonin reuptake inhibitors (SSRIs) by its dual action on norepinephrine and serotonin release and its strong antihistamine effect. Compared with many SSRIs, it often causes more sedation and weight gain but may be advantageous for patients with insomnia or poor appetite.

Mirtazapina Krka should be stored at room temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture, heat and direct sunlight, and ensure the container is tightly closed to maintain product stability.

The medication is taken orally, usually as a tablet, with a glass of water. It can be taken with or without food, although taking it with a light snack may reduce gastrointestinal discomfort. Patients should follow the dosing schedule prescribed by their healthcare professional.

Serious adverse reactions include agranulocytosis or severe neutropenia, severe hypersensitivity such as rash or angioedema, and the emergence or worsening of suicidal thoughts, especially during the early treatment phase. Prompt medical attention is required if any of these events occur.

Mirtazapina Krka is contraindicated in patients with known hypersensitivity to mirtazapine or any of its excipients, and in those currently receiving monoamine oxidase inhibitors (MAOIs) or who have taken an MAOI within the past 14 days. Caution is also advised for individuals with severe hepatic impairment or uncontrolled cardiovascular disease.